{"id":"https://openalex.org/W193250183","doi":null,"title":"Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.","display_name":"Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.","publication_year":2014,"publication_date":"2014-04-01","ids":{"openalex":"https://openalex.org/W193250183","mag":"193250183","pmid":"https://pubmed.ncbi.nlm.nih.gov/24692724"},"language":"en","primary_location":{"id":"pmid:24692724","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24692724","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018611620","display_name":"Sherif Abdelhamed","orcid":"https://orcid.org/0000-0002-3319-2403","observed_orcids":["https://orcid.org/0000-0002-3319-2403"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]},{"id":"https://openalex.org/I4405287106","display_name":"Institute of Natural Medicine, University of Toyama","ror":"https://ror.org/0449t5597","country_code":"JP","type":"facility","lineage":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Sherif Abdelhamed","raw_affiliation_strings":["Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. byosei@inm.u-toyama.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. byosei@inm.u-toyama.ac.jp","institution_ids":["https://openalex.org/I42766147","https://openalex.org/I4405287106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058893970","display_name":"Satoru Yokoyama","orcid":"https://orcid.org/0000-0001-8336-486X","observed_orcids":["https://orcid.org/0000-0001-8336-486X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Satoru Yokoyama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026662718","display_name":"Alaa Refaat","orcid":"https://orcid.org/0000-0002-7821-2500","observed_orcids":["https://orcid.org/0000-0002-7821-2500"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alaa Refaat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062520024","display_name":"Keisuke Ogura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keisuke Ogura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070494006","display_name":"Hideo Yagita\u2225","orcid":"https://orcid.org/0000-0003-4279-9343","observed_orcids":["https://orcid.org/0000-0003-4279-9343"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideo Yagita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062232507","display_name":"Suresh Awale","orcid":"https://orcid.org/0000-0002-5299-193X","observed_orcids":["https://orcid.org/0000-0002-5299-193X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suresh Awale","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111421980","display_name":"Ikuo Saiki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ikuo Saiki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.529,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.92083925,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"34","issue":"4","first_page":"1893","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13037","display_name":"Piperaceae Chemical and Biological Studies","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13037","display_name":"Piperaceae Chemical and Biological Studies","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.01769999973475933,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/piperine","display_name":"piperine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.890999972820282},{"id":"https://openalex.org/keywords/trail","display_name":"TRAIL","score":0.8859999775886536},{"id":"https://openalex.org/keywords/tumor-necrosis-factor-related-apoptosis-inducing-ligand","display_name":"tumor necrosis factor-related apoptosis-inducing ligand","score":0.9229999780654907},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/natural-products","display_name":"natural products","score":0.574999988079071},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6480000019073486},{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.8510000109672546},{"id":"https://openalex.org/keywords/nf-kappab-p65-phosphorylation","display_name":"p65 phosphorylation","score":0.9039999842643738},{"id":"https://openalex.org/keywords/orthotopic-tumor-model","display_name":"orthotopic tumor model","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.8300045728683472},{"id":"https://openalex.org/C2775934118","wikidata":"https://www.wikidata.org/wiki/Q424169","display_name":"Propidium iodide","level":4,"score":0.6533215641975403},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6040146350860596},{"id":"https://openalex.org/C2775975398","wikidata":"https://www.wikidata.org/wiki/Q906904","display_name":"Survivin","level":3,"score":0.5737789273262024},{"id":"https://openalex.org/C2780133158","wikidata":"https://www.wikidata.org/wiki/Q414501","display_name":"Piperine","level":2,"score":0.5600242614746094},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.554697573184967},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5075949430465698},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5072922110557556},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4662662148475647},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4381810426712036},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37832045555114746},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3644980788230896},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3232136070728302},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2937931418418884},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18999412655830383},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.12466558814048767},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07132095098495483},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077022","descriptor_name":"Survivin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000470","descriptor_name":"Alkaloids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000470","descriptor_name":"Alkaloids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051034","descriptor_name":"Inhibitor of Apoptosis Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051996","descriptor_name":"Transcription Factor RelA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052117","descriptor_name":"Benzodioxoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D052117","descriptor_name":"Benzodioxoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D053284","descriptor_name":"Polyunsaturated Alkamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D053284","descriptor_name":"Polyunsaturated Alkamides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:24692724","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24692724","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:193250183","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24692724","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1993508720","https://openalex.org/W1996353239","https://openalex.org/W1998231892","https://openalex.org/W2005289326","https://openalex.org/W2008742438","https://openalex.org/W2009098686","https://openalex.org/W2038301672","https://openalex.org/W2043135374","https://openalex.org/W2047914836","https://openalex.org/W2048129284","https://openalex.org/W2050252023","https://openalex.org/W2067850609","https://openalex.org/W2068677696","https://openalex.org/W2101867325","https://openalex.org/W2109232632","https://openalex.org/W2118356995","https://openalex.org/W2127967682","https://openalex.org/W2146869799","https://openalex.org/W2159999972","https://openalex.org/W2161888789","https://openalex.org/W2408721985"],"related_works":["https://openalex.org/W2170408243","https://openalex.org/W2127444343","https://openalex.org/W2594000079","https://openalex.org/W4401370463","https://openalex.org/W1996353239","https://openalex.org/W1971723332","https://openalex.org/W7006983671","https://openalex.org/W2769894263","https://openalex.org/W1873008523","https://openalex.org/W3004576606"],"abstract_inverted_index":{"BACKGROUND/AIM:":[0],"Triple-negative":[1],"breast":[2,11],"cancer":[3,12],"(TNBC)":[4],"is":[5,14,27],"most":[6,24,118],"the":[7,23,40,85,105,117,123],"aggressive":[8],"type":[9],"of":[10,22,42,100,125,142],"and":[13,66,68,79,91,133,144],"poorly":[15],"responsive":[16],"to":[17],"endocrine":[18],"therapeutics;":[19],"however,":[20],"one":[21],"attractive":[25],"treatments":[26],"tumor":[28],"necrosis":[29],"factor-related":[30],"apoptosis-inducing":[31],"ligand":[32],"(TRAIL)-based":[33],"therapies.":[34],"To":[35],"identify":[36],"compounds":[37,48],"that":[38],"enhance":[39,150],"efficacy":[41,124],"TRAIL-based":[43,126,151],"therapies,":[44],"we":[45,113],"screened":[46],"55":[47],"from":[49],"natural":[50],"products":[51],"in":[52,56,104,128,131,134],"combination":[53],"with":[54],"TRAIL":[55],"TNBC":[57,63,70,129],"cells.":[58],"MATERIALS":[59],"AND":[60],"METHODS:":[61],"Human":[62],"cells,":[64,71,78],"MDA-MB-468":[65],"MDA-MB-231,":[67],"murine":[69],"4T1,":[72],"were":[73,82,102],"used.":[74],"Cell":[75],"viability,":[76],"apoptotic":[77],"cell":[80],"cycle":[81],"quantified":[83],"by":[84],"WST-1":[86],"assay,":[87],"annexin-V/7-amino-actinomycinD":[88],"(7-AAD)":[89],"staining":[90],"Propidium":[92],"iodide":[93],"(PI)":[94],"staining,":[95],"respectively.":[96],"In":[97],"vivo":[98],"effects":[99],"piperine":[101,115],"evaluated":[103],"orthotopic-inoculated":[106],"4T1-luc":[107],"mouse":[108],"model.":[109],"RESULTS:":[110],"After":[111],"screening,":[112],"identified":[114],"as":[116],"potent":[119],"adjuvant":[120],"at":[121],"enhancing":[122],"therapies":[127],"cells":[130],"vitro":[132],"vivo,":[135],"which":[136],"might":[137],"be":[138],"mediated":[139],"through":[140],"inhibition":[141],"survivin":[143],"p65":[145],"phosphorylation.":[146],"CONCLUSION:":[147],"Piperine":[148],"may":[149],"therapeutics":[152],"for":[153],"TNBC.":[154]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}